Insider · CIK 0001046352

SANDAGE BOBBY W. JR., PHD.

Reports to the SEC for 4 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001046352

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-20	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+258K sh	—	—	258,171
2017-06-09	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+121K sh	—	—	121,483
2016-10-25	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+136K sh	—	—	135,612
2013-04-05	FBIOFortress Biotech, Inc.G Gift	Director, President	GGift	−3,000 sh	—	—	22,311
2012-11-30	FBIOFortress Biotech, Inc.P Purchase	Director, President	PPurchase	+3,811 sh	$4.02	+$15.3K	25,311
2012-06-22	FBIOFortress Biotech, Inc.P Purchase	Director, President	PPurchase	+10K sh	$5.00	+$50K	21,500
2012-01-12	FBIOFortress Biotech, Inc.P Purchase	Director, President	PPurchase	+1,000 sh	$5.20	+$5,195.2	1,500
2012-01-11	FBIOFortress Biotech, Inc.P Purchase	Director, President	PPurchase	+500 sh	$5.28	+$2,642	500
2009-02-24	Endo Pharmaceuticals Solutions Inc.U Disposition from Tender	Executive Vice President	UDisposition from Tender	−100K sh	—	—	0
2009-02-23	Endo Pharmaceuticals Solutions Inc.U Disposition from Tender	Executive Vice President	UDisposition from Tender	−131K sh	—	—	0
2009-02-23	Endo Pharmaceuticals Solutions Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+100K sh	—	—	100,443
2009-02-23	Endo Pharmaceuticals Solutions Inc.Performance Stock AwardsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−100K sh	—	—	18,174
2008-09-25	Endo Pharmaceuticals Solutions Inc.A Award	Executive Vice President	AAward	+55.9K sh	—	—	130,601
2008-09-25	Endo Pharmaceuticals Solutions Inc.Performance RightsA Award	Executive Vice President	AAward	0 sh	—	—	0
2007-10-30	Endo Pharmaceuticals Solutions Inc.A Award	Executive Vice President	AAward	+13.5K sh	—	—	74,683
2007-10-30	Endo Pharmaceuticals Solutions Inc.Performance RightsA Award	Executive Vice President	AAward	0 sh	—	—	0
2005-09-30	Endo Pharmaceuticals Solutions Inc.A Award	Executive Vice President	AAward	+2,274 sh	$2.37	+$5,389.38	60,313
2004-10-01	Endo Pharmaceuticals Solutions Inc.A Award	Executive Vice President	AAward	+10K sh	$2.38	+$23.8K	68,039
2004-10-01	Endo Pharmaceuticals Solutions Inc.S Sale	Executive Vice President	SSale	−10K sh	$7.13	−$71.3K	58,039
2004-10-01	Endo Pharmaceuticals Solutions Inc.A Award	Executive Vice President	AAward	+15K sh	$2.38	+$35.6K	73,039
2004-10-01	Endo Pharmaceuticals Solutions Inc.S Sale	Executive Vice President	SSale	−15K sh	$7.13	−$107K	58,039
2004-10-01	Endo Pharmaceuticals Solutions Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−10K sh	$2.38	−$23.8K	452,500
2004-10-01	Endo Pharmaceuticals Solutions Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−15K sh	$2.38	−$35.6K	437,500
2004-08-20	Endo Pharmaceuticals Solutions Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+10K sh	$2.38	+$23.8K	68,039
2004-08-20	Endo Pharmaceuticals Solutions Inc.G Gift	Executive Vice President	GGift	−10K sh	$6.85	−$68.5K	58,039
2004-08-20	Endo Pharmaceuticals Solutions Inc.Common stock, $0.001 par valueM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−10K sh	$2.38	−$23.8K	32,105
2003-09-30	Endo Pharmaceuticals Solutions Inc.A Award	Executive Vice President	AAward	+4,646 sh	$2.13	+$9,895.98	76,874
1999-07-13	GENTA INC DE/Non-Employee Directors' 1998 Stock Option Plan OptionsA Award	Director	AAward	−50K sh	—	—	387,500

Recent filings

Accepted (ET)
Jun 224
SANDAGE BOBBY W. JR., PHD.0001209191-18-039183
SEC(opens sec.gov)
Jun 124
MATEON THERAPEUTICS INC0001209191-17-039319
SEC(opens sec.gov)
Oct 274
MATEON THERAPEUTICS INC0001209191-16-147151
SEC(opens sec.gov)
Apr 164
SANDAGE BOBBY W PHD0001181431-13-022348
SEC(opens sec.gov)
Dec 34
SANDAGE BOBBY W PHD0001181431-12-061834
SEC(opens sec.gov)
Jun 264
SANDAGE BOBBY W PHD0001181431-12-037985
SEC(opens sec.gov)
Jan 124
SANDAGE BOBBY W PHD0001209191-12-003499
SEC(opens sec.gov)
Feb 254
SANDAGE BOBBY W PHD0001181431-09-011285
SEC(opens sec.gov)
Sep 294
INDEVUS PHARMACEUTICALS INC0001181431-08-054740
SEC(opens sec.gov)
Nov 14
SANDAGE BOBBY W PHD0001181431-07-065475
SEC(opens sec.gov)
Oct 44
INDEVUS PHARMACEUTICALS INC0001181431-05-054975
SEC(opens sec.gov)
Oct 44
INDEVUS PHARMACEUTICALS INC0001181431-04-046459
SEC(opens sec.gov)

Companies

Address

33 HAYDEN AVENUE

LEXINGTON, MA, 02421